915 related articles for article (PubMed ID: 33092283)
21. Targeting citrate as a novel therapeutic strategy in cancer treatment.
Huang L; Wang C; Xu H; Peng G
Biochim Biophys Acta Rev Cancer; 2020 Jan; 1873(1):188332. PubMed ID: 31751601
[TBL] [Abstract][Full Text] [Related]
22. Emerging functional markers for cancer stem cell-based therapies: Understanding signaling networks for targeting metastasis.
Marquardt S; Solanki M; Spitschak A; Vera J; Pützer BM
Semin Cancer Biol; 2018 Dec; 53():90-109. PubMed ID: 29966677
[TBL] [Abstract][Full Text] [Related]
23. Clinical development of cancer therapeutics that target metabolism.
Clem BF; O'Neal J; Klarer AC; Telang S; Chesney J
QJM; 2016 Jun; 109(6):367-72. PubMed ID: 26428335
[TBL] [Abstract][Full Text] [Related]
24. Long Non-Coding RNAs as Mediators of Tumor Microenvironment and Liver Cancer Cell Communication.
Lin YH; Wu MH; Yeh CT; Lin KH
Int J Mol Sci; 2018 Nov; 19(12):. PubMed ID: 30477236
[TBL] [Abstract][Full Text] [Related]
25. Drugging cancer metabolism: Expectations vs. reality.
Montrose DC; Galluzzi L
Int Rev Cell Mol Biol; 2019; 347():1-26. PubMed ID: 31451211
[TBL] [Abstract][Full Text] [Related]
26. Metabolic reprogramming in the tumour microenvironment: a hallmark shared by cancer cells and T lymphocytes.
Allison KE; Coomber BL; Bridle BW
Immunology; 2017 Oct; 152(2):175-184. PubMed ID: 28621843
[TBL] [Abstract][Full Text] [Related]
27. Mitochondria-centric bioenergetic characteristics in cancer stem-like cells.
Shin MK; Cheong JH
Arch Pharm Res; 2019 Feb; 42(2):113-127. PubMed ID: 30771209
[TBL] [Abstract][Full Text] [Related]
28. Harnessing Metabolic Reprogramming to Improve Cancer Immunotherapy.
Yan L; Tan Y; Chen G; Fan J; Zhang J
Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638609
[TBL] [Abstract][Full Text] [Related]
29. Targeting mTOR and Metabolism in Cancer: Lessons and Innovations.
Magaway C; Kim E; Jacinto E
Cells; 2019 Dec; 8(12):. PubMed ID: 31817676
[TBL] [Abstract][Full Text] [Related]
30. The Microenvironment of Lung Cancer and Therapeutic Implications.
Mittal V; El Rayes T; Narula N; McGraw TE; Altorki NK; Barcellos-Hoff MH
Adv Exp Med Biol; 2016; 890():75-110. PubMed ID: 26703800
[TBL] [Abstract][Full Text] [Related]
31. Targeting Mitochondrial Function to Treat Quiescent Tumor Cells in Solid Tumors.
Zhang X; de Milito A; Olofsson MH; Gullbo J; D'Arcy P; Linder S
Int J Mol Sci; 2015 Nov; 16(11):27313-26. PubMed ID: 26580606
[TBL] [Abstract][Full Text] [Related]
32. Targeting signal transduction pathways of cancer stem cells for therapeutic opportunities of metastasis.
Iqbal W; Alkarim S; AlHejin A; Mukhtar H; Saini KS
Oncotarget; 2016 Nov; 7(46):76337-76353. PubMed ID: 27486983
[TBL] [Abstract][Full Text] [Related]
33. Metabolic crosstalk in the breast cancer microenvironment.
Dias AS; Almeida CR; Helguero LA; Duarte IF
Eur J Cancer; 2019 Nov; 121():154-171. PubMed ID: 31581056
[TBL] [Abstract][Full Text] [Related]
34. TLR-mediated metabolic reprogramming in the tumor microenvironment: potential novel strategies for cancer immunotherapy.
Huang L; Xu H; Peng G
Cell Mol Immunol; 2018 May; 15(5):428-437. PubMed ID: 29553135
[TBL] [Abstract][Full Text] [Related]
35. Crosstalk between autophagy and metabolic regulation of cancer stem cells.
El Hout M; Cosialls E; Mehrpour M; Hamaï A
Mol Cancer; 2020 Feb; 19(1):27. PubMed ID: 32028963
[TBL] [Abstract][Full Text] [Related]
36. Metabolic reprogramming of the tumour microenvironment.
Xing Y; Zhao S; Zhou BP; Mi J
FEBS J; 2015 Oct; 282(20):3892-8. PubMed ID: 26255648
[TBL] [Abstract][Full Text] [Related]
37. Metabolic Reprogramming of Cancer Associated Fibroblasts: The Slavery of Stromal Fibroblasts.
Avagliano A; Granato G; Ruocco MR; Romano V; Belviso I; Carfora A; Montagnani S; Arcucci A
Biomed Res Int; 2018; 2018():6075403. PubMed ID: 29967776
[TBL] [Abstract][Full Text] [Related]
38. Understanding the cancer stem cell phenotype: A step forward in the therapeutic management of cancer.
Wong ALA; Bellot GL; Hirpara JL; Pervaiz S
Biochem Pharmacol; 2019 Apr; 162():79-88. PubMed ID: 30689981
[TBL] [Abstract][Full Text] [Related]
39. Modulation of Mitochondrial Metabolic Reprogramming and Oxidative Stress to Overcome Chemoresistance in Cancer.
Avolio R; Matassa DS; Criscuolo D; Landriscina M; Esposito F
Biomolecules; 2020 Jan; 10(1):. PubMed ID: 31947673
[TBL] [Abstract][Full Text] [Related]
40. Drug discovery strategies in the field of tumor energy metabolism: Limitations by metabolic flexibility and metabolic resistance to chemotherapy.
Amoedo ND; Obre E; Rossignol R
Biochim Biophys Acta Bioenerg; 2017 Aug; 1858(8):674-685. PubMed ID: 28213330
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
